Mr. Tyler has had over 50 years of experience in the areas of pharmaceutical process development, manufacturing, and CMC drug development management with both large pharmaceutical and smaller biotechnology companies. He received his B.S in Chemical Engineering from Carnegie Mellon University and an M.S. in Biochemical Engineering from Cornell University. Previously he was Vice President CMC for Shattuck Labs and has worked for GelTex Pharmaceuticals, Salix Pharmaceuticals, Momenta Pharmaceuticals, Proteon Therapeutics, KBI BioPharma, and Aeglea Biotherapeutics. Mr. Tyler has managed the chemistry, manufacturing, and controls development programs and ultimate approval of six new drugs.